Pierre Durozard

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Mass Spectrometry

Diffuse Large B Cell Lymphoma

Clinical Evaluation

Multiple Sclerosis

Top Venues

Neurology(R) neuroimmunology & neuroinflammation

Annals of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Roxane Claverie, Marine Perriguey, Audrey Rico, Clemence Boutiere, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Clea Dubrou, Frederic Vely, Jean Pelletier, Bertrand Audoin, Sandra Vukusic
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing? Neurology(R) neuroimmunology & neuroinflammation 10 (5) (2023)
Sarah Demortiere, Sandra Vukusic, Audrey Rico, Clemence Boutiere, Frederic Hilezian, Pierre Durozard, Jean Pelletier, Bertrand Audoin
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception. Neurology(R) neuroimmunology & neuroinflammation 10 (5) (2023)
Zélia Poullet, Julie Pique, Adil Maarouf, Clemence Boutiere, Audrey Rico, Sarah Demortiere, Pierre Durozard, Caroline Papeix, Elisabeth Maillart, Nicolas Collongues, Xavier Ayrignac, Helene Zephir, Romain Deschamps, Jonathan Ciron, Jean Pelletier, Romain Marignier, Bertrand Audoin
Pure Relapsing Short Myelitis: Part of the Multiple Sclerosis Spectrum or New Entity? Neurology(R) neuroimmunology & neuroinflammation 9 (4) (2022)
Pierre Durozard, Audrey Rico, Clémence Boutiere, Adil Maarouf, Romaric Lacroix, Sylvie Cointe, Shirley Fritz, Corinne Brunet, Jean Pelletier, Romain Marignier, Bertrand Audoin
Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases. Annals of neurology 87 (2) (2019)